文献速递腹部技术与安全CT

混合CT影像组学与术后病理模型预测胃肠道间质瘤患者无复发生存

Prediction of Recurrence-Free Survival in Patients with Gastrointestinal Stromal Tumors via Mixed CT Radiomics-Postoperative Pathology Models.
PubMed 文献 · Acad Radiol · 2026-03-05

本研究基于269例来自医院1的胃肠道间质瘤患者(训练集215例、内部验证集54例)及医院2的42例外部队列,构建并验证术前和术后无复发生存预测模型。术前模型整合影像组学、临床特征和CT视觉信息,术后模型加入病理信息。外部验证中,术前联合期相模型C指数0.787,术后联合期相模型C指数0.818,非增强CT效果与增强CT相似。

要点

  • 术后联合期相模型外部验证C指数0.818,高于术前联合期相模型0.787。
  • 非增强CT预测效果与增强CT相似。
  • 构建多预测因子列线图用于个体化无复发生存估计。

核心结论

  • 本研究在全风险等级(高、中、低及极低危)胃肠道间质瘤人群中建立了术前和术后无复发生存预测模型,可帮助临床医生制定个体化治疗方案以改善患者预后。

研究设计与样本

  • 回顾性研究纳入医院1的269例胃肠道间质瘤患者,随机分为训练集(n=215)和内部验证集(n=54);医院2的42例患者作为外部验证集;所有患者随访至少60个月;对整个肿瘤逐层进行3D分割并勾画感兴趣区(ROI),每个ROI提取851个影像组学特征;术前模型基于影像组学、临床特征和CT视觉信息建立,术后模型基于术前信息和病理信息构建。

诊断标准与关键数值

  • 外部验证中,术前预测模型基于非增强CT、动脉期、静脉期、延迟期和联合期的C指数分别为0.696、0.75、0.771、0.744和0.787。
  • 外部验证中,术后预测模型基于非增强CT、动脉期、静脉期、延迟期和联合期的C指数分别为0.776、0.764、0.783、0.766和0.818。
  • 非增强CT可获得与增强CT相似的效果。

临床应用与阅片要点

  • 构建了多预测因子列线图,用于个体化估计无复发生存。
  • 术前和术后模型覆盖高、中、低及极低危风险等级的胃肠道间质瘤人群。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: The purpose of this study was to develop and validate preoperative and postoperative recurrence-free survival (RFS) prediction models for patients with gastrointestinal stromal tumors (GISTs) of all risk levels in the gastric, small intestine, colorectal and extragastrointestinal regions.

MATERIALS AND METHODS: In total, 269 patients with GIST from hospital 1 were included and randomly divided into a training cohort (n=215) and an internal validation cohort (n=54). Another 42 patients from hospital 2 comprised the external validation cohort. All patients were followed up for at least 60 months. The whole tumor was 3D segmented and delineated as the region of interest (ROI) slice by slice, and 851 radiomic features were extracted from each ROI. Preoperative models were established on the basis of radiomics, clinical characteristics and CT visual information for RFS prediction. After surgery, the postoperative prediction models were constructed on the basis of preoperative information and pathological information.

RESULTS: In the external validation, the C indices of the preoperative prediction models based of nonenhanced CT and contrast-enhanced CT of arterial phase, venous phase, delayed phase and combined phase were 0.696, 0.75, 0.771, 0.744 and 0.787, respectively; while the C indices of the postoperative prediction model were 0.776, 0.764, 0.783, 0.766, and 0.818, respectively. Non-enhanced CT could achieve effects similar to those of contrast-enhanced CT. A multipredictor nomogram was constructed for individualized estimation of RFS.

CONCLUSION: This study established preoperative and postoperative models for the RFS prediction in a whole GIST population with high, medium, low and extremely low risk levels. It could help clinicians develop personalized treatment plans to improve patient prognosis.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Liu Y, He C, Gong C, et al. Prediction of Recurrence-Free Survival in Patients with Gastrointestinal Stromal Tumors via Mixed CT Radiomics-Postoperative Pathology Models. Acad Radiol. 2026. PMID: 41791907. doi:10.1016/j.acra.2026.02.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。